Separate names with a comma.
Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Apr 30, 2015 at 6:31 AM.
So what do you all have to say? Obviously vrx is doing great. Shorts will lose their shorts
Lots to say but to start, how about "interest rates"?
It looks like they will remain lower for longer. The party is not over for M&A.
Even if rates rise fx will also improve
